| 产品名称： | Blastomyces dermatitidis Gilchrist et Stokes |
|---|---|
| 商品货号： | TS170043 |
| Deposited As： | Blastomyces dermatitidis Gilchrist et Stokes, anamorph |
| Strain Designations： | B-47 |
| Alternate State： | Ajellomyces dermatitidis McDonough et Lewis |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Drug-induced alterations in ultrastructure uptake of sulfur-containing compounds GC content |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 25.0°C |
| Name of Depositor： | RG Garrison |
| Chain of Custody： | ATCC < |
| References： | Bawdon RE, et al. Deoxyribonucleic acid base composition of the yeastlike and mycelial phases of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 111: 593-596, 1972. PubMed: 5053471 Garrison RG, et al. The uptake of low molecular weight sulfur-containing compounds by Histoplasma capsulatum and related dimorphic fungi. Mycopathol. Mycol. Appl. 40: 171-180, 1970. PubMed: 5455792 Lane JW, et al. Drug-induced alterations in the ultrastructural organization of Histoplasma capsulatum and Blastomyces dermatitidis. Mycopathol. Mycol. Appl. 48: 289-296, 1972. PubMed: 4119289 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Blastomyces dermatitidis Gilchrist et Stokes |
|---|---|
| 商品货号： | TS170043 |
| Deposited As： | Blastomyces dermatitidis Gilchrist et Stokes, anamorph |
| Strain Designations： | B-47 |
| Alternate State： | Ajellomyces dermatitidis McDonough et Lewis |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Drug-induced alterations in ultrastructure uptake of sulfur-containing compounds GC content |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 25.0°C |
| Name of Depositor： | RG Garrison |
| Chain of Custody： | ATCC < |
| References： | Bawdon RE, et al. Deoxyribonucleic acid base composition of the yeastlike and mycelial phases of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 111: 593-596, 1972. PubMed: 5053471 Garrison RG, et al. The uptake of low molecular weight sulfur-containing compounds by Histoplasma capsulatum and related dimorphic fungi. Mycopathol. Mycol. Appl. 40: 171-180, 1970. PubMed: 5455792 Lane JW, et al. Drug-induced alterations in the ultrastructural organization of Histoplasma capsulatum and Blastomyces dermatitidis. Mycopathol. Mycol. Appl. 48: 289-296, 1972. PubMed: 4119289 |
